AC
Armistice Capital Portfolio holdings
AUM
$2.64B
This Quarter Return
+1.45%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$4.3B
AUM Growth
+$4.3B
(+12%)
Cap. Flow
+$486M
Cap. Flow
% of AUM
11.31%
Top 10 Holdings %
Top 10 Hldgs %
29.76%
Holding
319
New
63
Increased
77
Reduced
60
Closed
90
Top Buys
| 1 |
Neurocrine Biosciences
NBIX
|
$97M |
| 2 |
Exact Sciences
EXAS
|
$90.9M |
| 3 |
Icon
ICLR
|
$87.7M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$71.6M |
| 5 |
GSK
GSK
|
$62.7M |
Top Sells
| 1 |
Alkermes
ALKS
|
$40.5M |
| 2 |
PTC Therapeutics
PTCT
|
$38.7M |
| 3 |
Shake Shack
SHAK
|
$34.8M |
| 4 |
Incyte
INCY
|
$29.6M |
| 5 |
Cytokinetics
CYTK
|
$27.5M |
Sector Composition
| 1 | Healthcare | 67.09% |
| 2 | Consumer Discretionary | 10.89% |
| 3 | Consumer Staples | 9.15% |
| 4 | Technology | 8.92% |
| 5 | Communication Services | 1.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Ross Stores
ROST
$49.3B
| $15.8M | 0.22% |
104,690
-9,622
| -8% | -$1.46M |
|
|
NBIS
77
Nebius Group N.V. Class A Ordinary Shares
NBIS
$15.7B
| $15.5M | 0.21% |
+560,908
| New | +$15.5M |
|
|
CKPT
78
DELISTED
Checkpoint Therapeutics
CKPT
| $14.3M | 0.19% |
4,460,545
+574,545
| +15% | +$1.84M |
|
|
NVRO
79
DELISTED
NEVRO CORP.
NVRO
| $13.9M | 0.19% |
3,736,000
+8,000
| +0.2% | +$29.8K |
|
80
Lowe's Companies
LOW
$146B
| $13.6M | 0.19% |
55,157
+2,122
| +4% | +$524K |
|
81
SharkNinja
SN
$16.7B
| $13.4M | 0.18% |
+137,821
| New | +$13.4M |
|
82
Edwards Lifesciences
EW
$47.7B
| $12.6M | 0.17% |
169,829
+4,834
| +3% | +$358K |
|
83
BJ's Restaurants
BJRI
$749M
| $12.3M | 0.17% |
350,000
+200,000
| +133% | +$7.03M |
|
84
Smith & Nephew
SNN
$16.2B
| $12.1M | 0.17% |
494,000
+270,000
| +121% | +$6.64M |
|
|
BLTE
85
Belite Bio
BLTE
$2.09B
| $10.6M | 0.14% |
+167,930
| New | +$10.6M |
|
86
Foot Locker
FL
$2.3B
| $10.6M | 0.14% |
485,000
-170,000
| -26% | -$3.7M |
|
87
BILL Holdings
BILL
$4.69B
| $10.5M | 0.14% |
124,291
-80,485
| -39% | -$6.82M |
|
88
Alibaba
BABA
$325B
| $10.5M | 0.14% |
+124,000
| New | +$10.5M |
|
89
Thermo Fisher Scientific
TMO
$183B
| $10.4M | 0.14% |
20,044
-12,109
| -38% | -$6.3M |
|
90
Ulta Beauty
ULTA
$23.8B
| $10.4M | 0.14% |
23,845
-3,564
| -13% | -$1.55M |
|
91
Axogen
AXGN
$718M
| $10.1M | 0.14% |
613,000
+212,945
| +53% | +$3.51M |
|
92
TSMC
TSM
$1.2T
| $9.87M | 0.13% |
50,000
-25,000
| -33% | -$4.94M |
|
93
Levi Strauss
LEVI
$8.91B
| $9.52M | 0.13% |
550,000
-520,000
| -49% | -$9M |
|
94
Illumina
ILMN
$15.2B
| $9.37M | 0.13% |
70,083
+62,955
| +883% | +$8.41M |
|
95
Capri Holdings
CPRI
$2.51B
| $9.16M | 0.13% |
+435,000
| New | +$9.16M |
|
96
Glaukos
GKOS
$5.42B
| $8.83M | 0.12% |
+58,919
| New | +$8.83M |
|
|
GB
97
DELISTED
Global Blue Group Holding
GB
| $8.42M | 0.11% |
1,214,475
| – | – |
|
98
CRISPR Therapeutics
CRSP
$4.82B
| $8.19M | 0.11% |
208,000
+8,000
| +4% | +$315K |
|
99
AngioDynamics
ANGO
$432M
| $7.99M | 0.11% |
872,000
-90,000
| -9% | -$824K |
|
100
RH
RH
$4.14B
| $7.85M | 0.11% |
+19,941
| New | +$7.85M |
|